Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Retinopathy (DR): early-phase trial registry
2 of 6 indexed Diabetic Retinopathy (DR) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Diabetic Retinopathy (DR): 6 US clinical trials tracked, 2 recruiting.
Diabetic Retinopathy (DR) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is AEYE Health, running 1 of these trials.
Enrollment posture brief
Registry condition diabetic-retinopathy-dr
OPEN 2 | RECR 33% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Diabetic Retinopathy (DR) lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Retinopathy (DR) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Retinopathy (DR) is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Diabetic Retinopathy (DR) research.
AEYE Health accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Retinopathy (DR) enrolment sits around 548 participants.
Median target enrolment is 548 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Diabetic Retinopathy (DR) splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Assessment of AI Program 'DRISTi' as a Screening Tool
Artelus AI
NCT07222293
Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
University of Illinois at Chicago
NCT07296952
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence
Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health
NCT06721351
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
Interstat
NCT07216677
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
AbbVie
NCT04567550
Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images
AEYE Health
NCT06241664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Retinopathy (DR) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Retinopathy (DR) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Retinopathy (DR) page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Diabetic Retinopathy (DR) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AEYE Health sponsors the most Diabetic Retinopathy (DR) trials on record, review their full trial history before evaluating a specific study. See AEYE Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Retinopathy (DR) condition card totals 6 registered trials; most-linked intervention AEYE-DS Software; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.